The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.

ABSTRACT:

SUBMITTER: Godwin CD 

PROVIDER: S-EPMC7103514 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature